These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35103115)

  • 21. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
    Zhu Y; Geng S; Li Q; Jiang H
    Front Bioeng Biotechnol; 2020; 8():557652. PubMed ID: 33224928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm-A Powerful Therapeutic Tool for COVID-19 Patients.
    Csobonyeiova M; Smolinska V; Harsanyi S; Ivantysyn M; Klein M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update.
    Sang L; Guo X; Shi J; Hou S; Fan H; Lv Q
    Stem Cells Int; 2021; 2021():5593584. PubMed ID: 34211556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell therapy: A promising treatment for COVID-19.
    Zheng ZX
    World J Clin Cases; 2021 Dec; 9(36):11148-11155. PubMed ID: 35071545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells and COVID-19: What they do and what they can do.
    Abu-El-Rub E; Khasawneh RR; Almahasneh F; Altaany Z; Bataineh N; Zegallai H; Sekaran S
    World J Stem Cells; 2021 Sep; 13(9):1318-1337. PubMed ID: 34630865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
    Pourgholaminejad A; Pahlavanneshan S; Basiri M
    Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
    Machado C; González-Quevedo A
    MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
    Wang XY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
    Mannino F; Bitto A; Irrera N
    Front Pharmacol; 2020; 11():592169. PubMed ID: 33633566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
    Cai Q; Yin F; Hao L; Jiang W
    Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
    Kaye RJ
    Pain Physician; 2020 Aug; 23(4S):S421-S432. PubMed ID: 32942797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.
    Vaka R; Khan S; Ye B; Risha Y; Parent S; Courtman D; Stewart DJ; Davis DR
    Stem Cell Res Ther; 2022 Jan; 13(1):20. PubMed ID: 35033181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research.
    Coelho A; Alvites RD; Branquinho MV; Guerreiro SG; Maurício AC
    Front Cell Dev Biol; 2020; 8():602647. PubMed ID: 33330498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal Stem Cells in the Treatment of New Coronavirus Pandemic: A Novel Promising Therapeutic Approach.
    Razi S; Molavi Z; Mirmotalebisohi SA; Niknam Z; Sameni M; Niazi V; Adibi A; Yazdani M; Ranjbar MM; Zali H
    Adv Pharm Bull; 2022 Mar; 12(2):206-216. PubMed ID: 35620342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular Therapy: The Hope for Covid-19.
    Nobari S; Rezvan M; Dashtestani F; Gangi M; Keshmiri Neghab H
    Avicenna J Med Biotechnol; 2022; 14(2):104-113. PubMed ID: 35633981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis and treatment of cytokine storm in COVID-19.
    Soy M; Keser G; Atagündüz P
    Turk J Biol; 2021; 45(4):372-389. PubMed ID: 34803441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.